載入...
Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
BACKGROUND/PURPOSE: Spasticity is one of the most common symptoms in people with multiple sclerosis (MS). Conventional anti-spasticity agents have limitations in their efficacy and tolerability. Delta-9-tetrahydrocannabinol: cannabidiol (THC:CBD) spray, a cannabinoid-based medicine, is approved as a...
Na minha lista:
| 發表在: | J Cent Nerv Syst Dis |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413425/ https://ncbi.nlm.nih.gov/pubmed/30886530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179573519831997 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|